Transient Myeloproliferative Disorder
📧 Sign up to get email alerts when something new happens for Transient Myeloproliferative Disorder.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2015-09-30Clinical Trial Update: Low-Dose Cytarabine in Treating Infants With Down Syndrome and Transient Myeloproliferative Disorder [Phase 3]
Phase 3 trial of low-dose cytarabine for infants with Down syndrome and transient myeloproliferative disorder has been withdrawn.